CVE-2018-5379: Quagga bgpd

Double free in Quagga bgpd

CVSS 7.5 HighCriticalEPSS 0.38 · 98th percentile

Critical, because:

CVSS score 7.5 (7.0 or more) and EPSS 0.38 (0.1 or more): a high score and a real chance of exploitation in the next 30 days.

Published by the CVE Program (CNA: certcc) at 19 Feb 2018, 13:00 UTC. agentprime has not analysed this yet, so whether it affects any app is not known. This CVE names a vendor and product rather than a package, so the lockfile check doesn’t match it.

Affected products, as the CNA wrote them
Vendor	Product	Versions
Quagga	bgpd	affected bpgd to before 1.2.3 custom

Identifiers

CVE-2018-5379

CNA

certcc

Weakness (CWE)

CWE-415

Not analysed yet

We haven’t published our own analysis of this CVE. If a person reviews it, this page will say what’s affected and what has to be true for it to matter.

Severity and exploitation

Score	Rating	CVSS	Vector	Source
7.5	High	3.0	CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H	CNA (certcc)

CISA KEV Not listed.
EPSS 0.38, the 98th percentile, on 5 Nov 2026: FIRST’s estimate of the chance of exploitation in the next 30 days.

Timeline

This record came from the full history of the CVE Program, published 19 Feb 2018. New records show when each source confirmed them.

Sources

References from the CNA

usn.ubuntu.com/3573-1/ vendor-advisoryubuntu
www.debian.org/security/2018/dsa-4115 vendor-advisorydebian
www.securityfocus.com/bid/103105 vdb-entrybid
savannah.nongnu.org/forum/forum.php?forum_id=9095 confirm
security.gentoo.org/glsa/201804-17 vendor-advisorygentoo
gogs.quagga.net/Quagga/quagga/src/master/doc/security/Quagga-2018-1114.txt confirm
lists.debian.org/debian-lts-announce/2018/02/msg00021.html mailing-listmlist
www.kb.cert.org/vuls/id/940439 third-party-advisorycert-vn
access.redhat.com/errata/RHSA-2018:0377 vendor-advisoryredhat
cert-portal.siemens.com/productcert/pdf/ssa-451142.pdf confirm

Facts on this page come from the CVE List as the CNA published them, with CVSS from the sources named above, CISA KEV and FIRST EPSS. Vendors, products and versions are shown as the CNA wrote them. We don’t reproduce the CVE’s description.